Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs

NCT00005305 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT00005305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence and Consequences of Hepatitis Delta Virus Infection in Hemophiliacs
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Completed
Start date
September 30, 1987
Completion date
September 30, 1991
Enrollment
61 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

blood disease, hemophilia a, hepatitis, viral, human, liver diseases